Different types of systemic amyloidosis are recognized depending on the type of precursor protein of the amyloid fibril. [3] The three main types are amyloid A amyloidosis (AA), immunoglobulin ...

Dialysis causes altered metabolism of NT-proBNP. Recently, prognostic utility of serum uric acid in AL amyloidosis has been demonstrated in patients with cardiac involvement. This appeared to be ...

Dienes and colleagues are to be commended for discussing orthostatic hypotension, an underrecognized condition, in their recent CMAJ article.[1][1] In the extensive list of causes of orthostatic ...

Together, the findings in the bone marrow and fat-pad biopsy specimens were diagnostic of systemic immunoglobulin light-chain (AL) amyloidosis (the abnormal deposition of immunoglobulin light ...

NAPLES, Fla., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative products to improve the lives of patients with systemic amyloidosis ...

Other diseases.Systemic amyloidosis is a rare disease that causes amyloid protein to build up in your organs and tissues. This can affect your nails. Nail trauma. Injury to your nails, picking at ...

According to GlobalData, Phase II drugs for Systemic Lupus Erythematosus have a 39% phase ... for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis. Johnson & Johnson ...

Life Molecular Imaging (LMI), an international pharmaceutical company dedicated to developing and offering novel cutting-edge PET radiopharmaceuticals for imaging, announces that the U.S. Food and ...

Urinalysis tends to be normal; however, the finding of proteinuria should raise clinical concern for renal amyloidosis. 1 In our experience, inflammatory serologies usually revert to normal ...

While ATTRv-CM may appear in individuals aged in their 50s or 60s, ATTRwt-CM is more common and typically affects men aged over 60 years. The disease is often diagnosed only in advanced stages when ...

In the following sections, diagnostic and treatment strategies for specific cardiomyopathies such as cardiac amyloidosis, cardiotoxins, peripartum cardiomyopathy, cardiac sarcoidosis, myocarditis, ...